Lannett Co Inc Shares Outstanding 2006-2020 | LCI

Lannett Co Inc shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Lannett Co Inc Annual Shares Outstanding
(Millions of Shares)
2020 39
2019 38
2018 38
2017 37
2016 37
2015 37
2014 35
2013 29
2012 28
2011 27
2010 25
2009 25
2008 24
2007 24
2006 24
2005 24
Lannett Co Inc Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 39
2020-09-30 39
2020-06-30 39
2020-03-31 39
2019-12-31 41
2019-09-30 38
2019-06-30 38
2019-03-31 39
2018-12-31 39
2018-09-30 38
2018-06-30 38
2018-03-31 38
2017-12-31 38
2017-09-30 38
2017-06-30 37
2017-03-31 38
2016-12-31 38
2016-09-30 37
2016-06-30 37
2016-03-31 36
2015-12-31 37
2015-09-30 37
2015-06-30 37
2015-03-31 37
2014-12-31 37
2014-09-30 37
2014-06-30 35
2014-03-31 37
2013-12-31 36
2013-09-30 30
2013-06-30 29
2013-03-31 29
2012-12-31 28
2012-09-30 28
2012-06-30 28
2012-03-31 29
2011-12-31 29
2011-09-30 29
2011-06-30 27
2011-03-31 28
2010-12-31 26
2010-09-30 25
2010-06-30 25
2010-03-31 25
2009-12-31 25
2009-09-30 25
2009-06-30 25
2009-03-31 25
2008-12-31 25
2008-09-30 24
2008-06-30 24
2008-03-31 24
2007-12-31 24
2007-09-30 24
2007-06-30 24
2007-03-31 24
2006-12-31 24
2006-09-30 24
2006-06-30 24
2006-03-31 24
2005-12-31 24
2005-09-30 24
2005-06-30 24
2005-03-31 24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.204B $0.546B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.845B 43.66
Takeda Pharmaceutical (TAK) Japan $53.521B 9.80
Astellas Pharma (ALPMY) Japan $28.103B 17.35
Eisai (ESALY) Japan $20.036B 22.22
Catalent (CTLT) United States $18.492B 48.93
Grifols, S.A (GRFS) Spain $12.651B 14.72
Jazz Pharmaceuticals (JAZZ) Ireland $9.415B 15.73
United Therapeutics (UTHR) United States $9.080B 17.63
Neurocrine Biosciences (NBIX) United States $8.967B 20.66
IPSEN SA ADR (IPSEY) France $8.063B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.954B 0.00
Evotec AG (EVTCY) Germany $6.594B 445.28
Orion OYJ (ORINY) Finland $5.789B 20.11
Ionis Pharmaceuticals (IONS) United States $5.626B 0.00
Sage Therapeutics (SAGE) United States $4.382B 0.00
Hypermarcas (HYPMY) Brazil $3.997B 15.77
Turning Point Therapeutics (TPTX) United States $3.571B 0.00
Nektar Therapeutics (NKTR) United States $3.427B 0.00
PTC Therapeutics (PTCT) United States $3.343B 0.00
ChemoCentryx (CCXI) United States $3.124B 0.00
Tilray (TLRY) Canada $2.995B 0.00
Cronos Group (CRON) Canada $2.954B 0.00
Relay Therapeutics (RLAY) United States $2.950B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.904B 17.99
Revolution Medicines (RVMD) United States $2.888B 0.00
Pacira BioSciences (PCRX) United States $2.786B 47.04
Corcept Therapeutics (CORT) United States $2.686B 26.94
Organogenesis Holdings (ORGO) United States $2.685B 161.38
Xencor (XNCR) United States $2.430B 0.00
USANA Health Sciences (USNA) United States $2.076B 17.18
BioCryst Pharmaceuticals (BCRX) United States $2.045B 0.00
FibroGen (FGEN) United States $1.749B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.708B 13.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.703B 10.92
Heron Therapeutics (HRTX) United States $1.567B 0.00
Sundial Growers (SNDL) Canada $1.561B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.524B 0.00
AlloVir (ALVR) United States $1.468B 0.00
Indivior (INVVY) United States $1.460B 0.00
Translate Bio (TBIO) United States $1.446B 0.00
ImmunoGen (IMGN) United States $1.444B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.426B 0.00
Endo (ENDP) Ireland $1.358B 2.05
Aclaris Therapeutics (ACRS) United States $1.348B 0.00
Ocular Therapeutix (OCUL) United States $1.159B 0.00
Zogenix (ZGNX) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.006B 0.00
Trillium Therapeutics (TRIL) Canada $0.992B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.886B 0.00
4D Molecular Therapeutics (FDMT) $0.881B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Bioventus (BVS) United States $0.840B 0.00
Collegium Pharmaceutical (COLL) United States $0.819B 30.60
Aerie Pharmaceuticals (AERI) United States $0.816B 0.00
Esperion Therapeutics (ESPR) United States $0.757B 0.00
Karyopharm Therapeutics (KPTI) United States $0.693B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.672B 0.00
Chinook Therapeutics (KDNY) United States $0.650B 0.00
Rafael Holdings (RFL) United States $0.628B 0.00
Harpoon Therapeutics (HARP) United States $0.621B 0.00
VAXART, INC (VXRT) United States $0.602B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.591B 0.00
Nanobiotix S.A (NBTX) France $0.576B 0.00
KalVista Pharmaceuticals (KALV) United States $0.562B 0.00
Siga Technologies (SIGA) United States $0.551B 9.21
Crinetics Pharmaceuticals (CRNX) United States $0.534B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.514B 0.00
Sigilon Therapeutics (SGTX) $0.506B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.495B 0.00
Molecular Templates (MTEM) United States $0.465B 0.00
TherapeuticsMD (TXMD) United States $0.456B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.447B 10.51
Spectrum Pharmaceuticals (SPPI) United States $0.444B 0.00
Altimmune (ALT) United States $0.438B 0.00
Akebia Therapeutics (AKBA) United States $0.437B 0.00
Flexion Therapeutics (FLXN) United States $0.437B 0.00
AVITA Medical (RCEL) United States $0.435B 0.00
Summit Therapeutics (SMMT) United States $0.427B 0.00
PROFOUND MEDICL (PROF) Canada $0.407B 0.00
Foghorn Therapeutics (FHTX) United States $0.397B 0.00
Nature's Sunshine Products (NATR) United States $0.388B 18.49
Jounce Therapeutics (JNCE) United States $0.386B 0.00
DURECT (DRRX) United States $0.373B 0.00
Acutus Medical (AFIB) United States $0.364B 0.00
MEI Pharma (MEIP) United States $0.362B 0.00
Innate Pharma SA (IPHYF) France $0.352B 0.00
Redhill Biopharma (RDHL) Israel $0.315B 0.00
Oncternal Therapeutics (ONCT) United States $0.304B 0.00
Clever Leaves Holdings (CLVR) United States $0.278B 0.00
VYNE Therapeutics (VYNE) United States $0.263B 0.00
Alpine Immune Sciences (ALPN) United States $0.262B 0.00
Taiwan Liposome (TLC) Taiwan $0.256B 0.00
Infinity Pharmaceuticals (INFI) United States $0.253B 0.00
KemPharm (KMPH) United States $0.247B 0.00
Inotiv (NOTV) United States $0.238B 0.00
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.229B 0.00
Xeris Pharmaceuticals (XERS) United States $0.223B 0.00
4D Pharma (LBPS) United Kingdom $0.216B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.205B 0.00
Sierra Oncology (SRRA) Canada $0.200B 0.00
Progenity (PROG) United States $0.192B 0.00
OptiNose (OPTN) United States $0.185B 0.00
IMV INC (IMV) Canada $0.181B 0.00
CTI BioPharma (CTIC) United States $0.180B 0.00
Iterum Therapeutics (ITRM) Ireland $0.180B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.180B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.179B 0.00
Jaguar Animal Health (JAGX) United States $0.177B 0.00
Novan (NOVN) United States $0.173B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
Heat Biologics (HTBX) United States $0.161B 0.00
Calithera Biosciences (CALA) United States $0.158B 0.00
Gain Therapeutics (GANX) United States $0.158B 0.00
Qilian Holding Group (QLI) China $0.158B 0.00
SCYNEXIS (SCYX) United States $0.154B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.151B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Onconova Therapeutics (ONTX) United States $0.145B 0.00
Vivos Therapeutics (VVOS) $0.145B 0.00
Aquestive Therapeutics (AQST) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
Concert Pharmaceuticals (CNCE) United States $0.136B 0.00
MediWound (MDWD) Israel $0.134B 0.00
Aziyo Biologics (AZYO) United States $0.133B 0.00
GlycoMimetics (GLYC) United States $0.127B 0.00
Lipocine (LPCN) United States $0.123B 0.00
IsoRay (ISR) United States $0.117B 0.00
Otonomy (OTIC) United States $0.113B 0.00
Genocea Biosciences (GNCA) United States $0.112B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
Natural Alternatives (NAII) United States $0.108B 29.19
PolarityTE (PTE) United States $0.107B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.106B 0.00
Minerva Neurosciences (NERV) United States $0.103B 40.17
Savara (SVRA) United States $0.101B 0.00
AIM ImmunoTech (AIM) United States $0.098B 0.00
Nutriband (NTRB) United States $0.095B 0.00
ElectroCore (ECOR) United States $0.090B 0.00
Regulus Therapeutics (RGLS) United States $0.089B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
Assertio Holdings (ASRT) United States $0.083B 0.00
Recro Pharma (REPH) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Baudax Bio (BXRX) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
Sigyn Therapeutics (SIGY) United States $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Biomerica (BMRA) United States $0.058B 0.00
Brickell Biotech (BBI) United States $0.056B 0.00
AgeX Therapeutics (AGE) United States $0.053B 0.00
Inhibikase Therapeutics (IKT) United States $0.052B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.052B 0.00
HANCOCK JAFFE (HJLI) United States $0.051B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 59.80
Mannatech (MTEX) United States $0.041B 7.32
Viracta Therapeutics (VIRX) United States $0.039B 0.00
Can-Fite Biopharma (CANF) Israel $0.036B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
RXi Pharmaceuticals (PHIO) United States $0.030B 0.00
Petros Pharmaceuticals (PTPI) United States $0.029B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
JanOne (JAN) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 15.45
SHINECO INC (TYHT) China $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00